US struggles with increase of three respiratory viruses
The respiratory syncytial virus (RSV), which causes bronchiolitis in newborns, is severely affecting children.
According to specialists, the flu, COVID-19, and RSV infections are increasing concurrently and earlier than typical in the US, placing stress on hospitals.
The respiratory syncytial virus (RSV), which causes the chest infection bronchiolitis in newborns, is particularly bad for children and has led to exceptionally high hospitalisation rates this season in a number of nations throughout the world.
Director of the National Center for Immunization and Respiratory Diseases Jose Romero stated at a news conference that “we suspect that many youngsters are getting exposed to various respiratory viruses now for the first time having evaded these viruses during the height of the pandemic.”
Even though most patients recover within a week or two from all three circulating respiratory viruses, the very young and elderly are at risk of experiencing severe illness. All three respiratory viruses have similar symptoms.
According to him, there has been “heavy” activity for this time of year for visits to outpatient care providers and emergency rooms for cold-like symptoms including a fever or sore throat.
Going back a decade, “we’re seeing the greatest influenza hospitalisation rates.”
He advised parents to take children to the doctor immediately if they were having trouble breathing, had bluish lips, discomfort in their muscles, or appeared to be dehydrated.
Although it has started spreading exceptionally early, experts believe it is still difficult to assess whether the influenza virus this year was causing worse disease than typical.
Every week, more than 270,000 new instances of Covid-19 are reported in the US.
According to Dawn O’Connell, assistant secretary at the US Department of Health and Human Services, hospitals in the mid-Atlantic region, New England, and Washington state are “now under tremendous strain.”
US struggles with increase of three respiratory viruses
Two of the prevalent viruses—Covid-19 and the flu—can be prevented with vaccines, but child flu vaccination rates are significantly lower than they were before the pandemic.
This week, Pfizer said that a clinical trial for an RSV vaccine had yielded promising results. Over the past fifty years, scientists and researchers have been unable to develop a viable vaccination against the virus.
